Skip to main content
Clinical Trials/RBR-6yppv3
RBR-6yppv3
Recruiting
未知

Comparison of efficacy and safety in the treatment of severe chronic venous insufficiency: endovenous radiofrequency ablation versus endovenous laser ablation versus foam sclerotherapy versus elastic compression

nidade de Pesquisa Clínica-Faculdade de Medicina de Botucatu - Unesp0 sitesApril 3, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Varicose veins, venous insufficiency,varicose ulcer
Sponsor
nidade de Pesquisa Clínica-Faculdade de Medicina de Botucatu - Unesp
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 3, 2017
End Date
TBD
Last Updated
2 years ago
Study Type
Intervention

Investigators

Sponsor
nidade de Pesquisa Clínica-Faculdade de Medicina de Botucatu - Unesp

Eligibility Criteria

Inclusion Criteria

  • The study will include male and female patients 18 years old or older, with no limits on the maximum age,with active venous ulcers (CEAP 6\),primary varicose veins documented by ultrasound,and who agreed to the terms of the studyand signed the free, prior, and informed consent (FPIC).

Exclusion Criteria

  • Patients under 18 years of age; with venous anomalies (e.g. angiodysplasia); with history of deep venous thrombosis and post\-thrombotic syndrome; in use of anticoagulants; varicose veins classified as CEAP 5 or less; who had previous saphenectomy in the affected limb; without surgical or anesthetic conditions; with ulcers with signs of active infection; pregnant, postpartum or breastfeeding women; patients with history of migraine; history of interatrial or arteriovenous communication; with active cellulitis or erysipelas; abnormal laboratory liver or kidney function (creatinine clearance below 30ml/m); with signs of active skin mycosis; with previously known retinal changes; history of alcohol or drug abuse; signs of arterial insufficiencyclinically present; signs of clinically decompensated comorbidities; who do not agree with the terms of the study or refuse to sign the free and informed consent (FPIC).

Outcomes

Primary Outcomes

Not specified

Similar Trials